78 related articles for article (PubMed ID: 17724741)
41. Governmental influences on drug development: striking a better balance.
Miller HI; Henderson DR
Nat Rev Drug Discov; 2007 Jul; 6(7):532-9. PubMed ID: 17491596
[TBL] [Abstract][Full Text] [Related]
42. Drug development for children: how is pharma tackling an unmet need?
Hawcutt DB; Smyth RL
IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
[TBL] [Abstract][Full Text] [Related]
43. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
Baillie TA
Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
[TBL] [Abstract][Full Text] [Related]
44. The drug diagnostic co-development concept paper: commentary from the 3rd FDA-DIA-PWG-PhRMA-BIO Pharmacogenomics Workshop.
Hinman LM; Huang SM; Hackett J; Koch WH; Love PY; Pennello G; Torres-Cabassa A; Webster C
Pharmacogenomics J; 2006; 6(6):375-80. PubMed ID: 16652120
[TBL] [Abstract][Full Text] [Related]
45. [Safety assessment of new products developed by the pharmaceutical industry].
Claude JR
Ann Pharm Fr; 2001 Sep; 59(5):324-30. PubMed ID: 11787426
[TBL] [Abstract][Full Text] [Related]
46. [Dangerous liaisons--physicians and pharmaceutical sales representatives].
Granja M
Acta Med Port; 2005; 18(1):61-8. PubMed ID: 16202335
[TBL] [Abstract][Full Text] [Related]
47. Drug importation and safety of drugs obtained from Canada.
Shepherd M
Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
[TBL] [Abstract][Full Text] [Related]
48. Advances in knowledge management for pharmaceutical research and development.
Torr-Brown S
Curr Opin Drug Discov Devel; 2005 May; 8(3):316-22. PubMed ID: 15892246
[TBL] [Abstract][Full Text] [Related]
49. [Sanitary risk: medicinal products and medical devices].
Marimbert J
Rev Prat; 2005 Nov; 55(18):2026-32. PubMed ID: 16419907
[TBL] [Abstract][Full Text] [Related]
50. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.
McFadden DW; Calvario E; Graves C
J Surg Res; 2007 Jun; 140(1):1-5. PubMed ID: 17481979
[TBL] [Abstract][Full Text] [Related]
51. The art and science of risk management: a US research-based industry perspective.
Bush JK; Dai WS; Dieck GS; Hostelley LS; Hassall T
Drug Saf; 2005; 28(1):1-18. PubMed ID: 15649102
[TBL] [Abstract][Full Text] [Related]
52. Perspectives on the failure of pharmaceutical and medical device industries to fully protect public health interests.
Maron BJ; Hauser RG
Am J Cardiol; 2007 Jul; 100(1):147-51. PubMed ID: 17599459
[TBL] [Abstract][Full Text] [Related]
53. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.
de Wilde S; de Jong MGH; Le Brun PPH; Guchelaar HJ; Schimmel KJM
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193
[TBL] [Abstract][Full Text] [Related]
54. Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics.
Califf RM;
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):5-16. PubMed ID: 16506270
[TBL] [Abstract][Full Text] [Related]
55. Replacing an old drug with a new one.
Ferguson RP
Conn Med; 1991 Dec; 55(12):687-90. PubMed ID: 1790706
[TBL] [Abstract][Full Text] [Related]
56. A call for international harmonization in therapeutic risk management.
Hirst C; Cook S; Dai W; Perez-Gutthann S; Andrews E
Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):839-49; discussion 850-1. PubMed ID: 16981215
[TBL] [Abstract][Full Text] [Related]
57. Safety issues in scale-up of chemical processes.
Stoessel F
Curr Opin Drug Discov Devel; 2001 Nov; 4(6):834-9. PubMed ID: 11899622
[TBL] [Abstract][Full Text] [Related]
58. [Making Patient-focused Information Provision a Reality: One Company's Approach].
Takemoto S
Yakugaku Zasshi; 2018; 138(3):315-323. PubMed ID: 29503422
[TBL] [Abstract][Full Text] [Related]
59. Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead.
Leather DA; Davis SC
Paediatr Respir Rev; 2006 Mar; 7(1):60-6. PubMed ID: 16473819
[TBL] [Abstract][Full Text] [Related]
60. Effective risk communication practice.
Leiss W
Toxicol Lett; 2004 Apr; 149(1-3):399-404. PubMed ID: 15093287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
